The corporate stated it additionally expects to obtain a tax credit score shortly.
ValiRx PLC (LON:VAL) stated discussions to type a three way partnership with funding agency Alpha Blue Ocean haven’t progressed past what it instructed the market in Could and June.
Consequently, any deal brokered “can be thought of together with different alternatives”.
The replace got here because the drug developer stated Novum was its new nominated adviser after SVS Securities was positioned into administration.
ValiRx stated it expects to obtain a £400,000 R&D tax credit score shortly. Within the meantime, it continues to rigorously handle its working capital place.